X-ray-activatable Hitchhiking Polymer Nanodrugs Enable Controllable Ferroptosis and Immunization for Orthotopic Glioma Rejection

Anni Zhu,Wenzhi Tu,Mengbin Ding,Yijing Zhang,Jiansheng Liu,Xuming Chen,Liren Wang,Yong Liu,Jingchao Li
DOI: https://doi.org/10.1016/j.cej.2024.154652
IF: 15.1
2024-01-01
Chemical Engineering Journal
Abstract:While various tactics have been adopted to treat glioma, the clinical therapeutic efficacy of glioma is still poor due to its aggressiveness, blood–brain barrier (BBB), drug resistance and highly immunosuppressive microenvironment. We herein present X-ray-activatable hitchhiking polymer nanodrugs (HPNFcN) that can enable controlled ferroptosis and immunization for rejecting orthotopic glioma. HPNFcN are formed via loading a newly synthesized ferroptosis-inducing ferrocene prodrug and an immunotherapeutic drug (NLG919) into reactive oxygen species (ROS)-responsive semiconducting polymer nanosystems with surface embellishment of a neutrophil targeting ligand. We found that neutrophil-targeted HPNFcN could achieve effective delivery into the orthotopic glioma sites via acrossing BBB. Low-dose X-ray irradiation of HPNFcN resulted in the generation of ROS by semiconducting polymer, which not only activated the ferrocene prodrug to cause ferroptosis, but also wrecked the ROS-responsive nanosystems to on-demand deliver NLG919. Moreover, the ferroptosis effect triggered immunogenic cell death (ICD) to promote immunization, which synergized with the NLG919-based blockade for reinforcing antitumor immune response. Such a precise and effective therapeutic strategy could observably reject orthotopic glioma without significant side effects. This study demonstrates the superiorities of HPNFcN for glioma treatment via neutrophil-mediated effective delivery and X-ray-activatable therapeutic actions of ferroptosis and immunization.
What problem does this paper attempt to address?